This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AVY BWLD DHI MWV YUM


Aetna (AET) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $83. Company is keeping a tight lid on costs and should realize higher synergies from the CVH deal, Credit Suisse said.

Albermarle (ALB) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $71. See improved growth in catalysts over the coming quarters, BofA/Merrill said.

Avery Dennison (AVY) was upgraded at Robert Baird to outperform from neutral. Twelve-month price target is $57. Stock is trading at a discount to its peers and management should continue to execute, Robert Baird said.

American Axle & Manufacturing (AXL) was upgraded to buy at TheStreet Ratings.

Buffalo Wild Wings (BWLD - Get Report) was downgraded at Morgan Stanley to underweight. Valuation call, Morgan Stanley said. Twelve-month price target is $143.

CACI International (CACI) was upgraded at J.P. Morgan to overweight from neutral. Driven by relative value in SMID defense and an eventual shift back to the more typical pensions-adjusted EPS from GAAP as basis for valuing large-cap defense, J.P. Morgan said.

Must Read: Analysts' Actions: BKW CMG HP MCD PNRA

Commerce Bancshares (CBSH) was upgraded at Bank of America/Merrill Lynch to neutral. Twelve-month price target is $46. Margin stabilization should support spread revenue growth, BofA/Merrill said.

CVS Caremark (CVS) was initiated with an outperform rating at Leerink Swann. Twelve-month price target is $85. Retail and mail PBM model should drive growth, Leerink Swann said.

City National (CYN) was upgraded at Bank of America/Merrill Lynch to neutral from underperform. Twelve-month price target is $80. Company is leveraged to higher interest rates and can generate high growth, BofA/Merrill said.

Dupont (DD) was upgraded at Bank of America/Merrill Lynch to buy from neutral. Twelve-month price target is $70. Company is inexpensive and has leverage to growing demand for specialty chemicals, BofA/Merrill said.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BWLD $133.66 0.00%
DHI $30.06 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs